<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05127005</url>
  </required_header>
  <id_info>
    <org_study_id>TAUH_FINTASY</org_study_id>
    <nct_id>NCT05127005</nct_id>
  </id_info>
  <brief_title>Efficacy of Trapeziectomy Versus Sham Surgery in the Treatment of Osteoarthritis at the Base of the Thumb</brief_title>
  <acronym>FINTASY</acronym>
  <official_title>A Multi-center, Investigator-blinded, Randomized, Parallel Group, Superiority Study to Compare the Efficacy of Trapeziectomy Versus Sham Surgery in the Treatment of Osteoarthritis at the Base of the Thumb</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tampere University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Helsinki University Central Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Central Finland Central Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Eastern Finland</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Tampere University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A multi-center randomized placebo-controlled clinical trial which determines the efficacy of&#xD;
      trapeziectomy in patients with persistent painful osteoarthritis at the base of the thumb.&#xD;
      The primary outcome is patient reported evaluation of pain and function of the wrist and hand&#xD;
      at 6 months after the randomization to treatment group.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A multi-center randomized placebo-controlled clinical trial which determines the efficacy of&#xD;
      trapeziectomy in patients with persistent painful osteoarthritis at the base of the thumb&#xD;
      (CMC1). The primary outcome is Patient Reported Wrist and Hand Evaluation (PRWHE) at 6 months&#xD;
      after the randomization to treatment group. Secondary measures include PRWHE at 3 months, 1&#xD;
      year, 2 years and 5 years, grip strength, and global assessment of change.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">December 2021</start_date>
  <completion_date type="Anticipated">December 2029</completion_date>
  <primary_completion_date type="Anticipated">December 2024</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Patient reported wrist and hand evaluation (PRWHE)</measure>
    <time_frame>6 months</time_frame>
    <description>PROM questionnaire</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Patient reported wrist and hand evaluation (PRWHE)</measure>
    <time_frame>3 months, and 1, 2, 5 years</time_frame>
    <description>PROM questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Global improvement</measure>
    <time_frame>3 and 6 months, and 1, 2, and 5 years</time_frame>
    <description>PROM, question (Likert scale)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient accepted symptom state</measure>
    <time_frame>3 and 6 months, and 1, 2, and 5 years</time_frame>
    <description>PROM, question (Likert scale)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Grip and pinch strength</measure>
    <time_frame>6 months</time_frame>
    <description>Measured with dynamometer</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>EUROQOL EQ-5D-5L</measure>
    <time_frame>3 and 6 months, and 1, 2, and 5 years</time_frame>
    <description>PROM, health-related quality of life questionnaire</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">132</enrollment>
  <condition>Thumb Osteoarthritis</condition>
  <arm_group>
    <arm_group_label>Trapeziectomy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Trapeziectomy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham surgery</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Sham surgery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non-randomized observational arm</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Non-randomized observational arm (trapeziectomy, not blinded)</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Trapeziectomy</intervention_name>
    <description>Surgical excision of trapezoideum</description>
    <arm_group_label>Non-randomized observational arm</arm_group_label>
    <arm_group_label>Trapeziectomy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Sham</intervention_name>
    <description>Skin incision only</description>
    <arm_group_label>Sham surgery</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Primary thumb basal joint (CMC1) osteoarthritis (Eaton Glickel grade 2 or higher)&#xD;
             confirmed by standard x-rays and with symptoms limiting activities of daily living&#xD;
&#xD;
          2. Indication for surgical treatment of thumb basal joint (CMC1) osteoarthritis after&#xD;
             insufficient benefit from non-operative treatment, including use of a thumb orthosis&#xD;
             and pain medication (NSAIDs or paracetamol, implemented for at least three months.&#xD;
&#xD;
          3. Thumb pain in use of at least 4 on a 0 to10 numerical rating scale (NRS, 10=worst&#xD;
             pain)&#xD;
&#xD;
          4. Age &gt; 45 years&#xD;
&#xD;
          5. ASA-classification I-II (American Society for Anesthesiologist's Physical Status&#xD;
             Classification System)&#xD;
&#xD;
          6. Ability to speak, understand and read in the language of the clinical site&#xD;
&#xD;
          7. Provision of informed consent from the participant&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Patients' main complaint is due to some other problem than primary thumb basal joint&#xD;
             (CMC1) osteoarthritis or patient will undergo any other surgery in conjunction with&#xD;
             trapeziectomy&#xD;
&#xD;
          2. Neurologic condition affecting the function or symptoms of the upper extremity&#xD;
&#xD;
          3. &lt;6 months from other surgical procedure of the upper extremities&#xD;
&#xD;
          4. Rheumatoid arthritis or other inflammatory joint disease&#xD;
&#xD;
          5. Bilateral thumb basal joint (CMC1) osteoarthritis in which patient requests treatment&#xD;
             for both sides&#xD;
&#xD;
          6. Previous operation due tothumb basal joint (CMC1) osteoarthritis for either side&#xD;
&#xD;
          7. &gt;45 degrees of hyperextension in the thumb MP joint in resting position (zig zag&#xD;
             deformity)&#xD;
&#xD;
          8. Patient is unable to continue his/her current job due to thumb pain&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>45 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jarkko Jokihaara</last_name>
    <role>Study Chair</role>
    <affiliation>TAUH</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jarkko Jokihaara</last_name>
    <phone>+3583311611</phone>
    <email>jarkko.jokihaara@pshp.fi</email>
  </overall_contact>
  <location>
    <facility>
      <name>Helsinki University Central Hospital</name>
      <address>
        <city>Helsinki</city>
        <country>Finland</country>
      </address>
    </facility>
    <contact>
      <last_name>Eero Waris</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Central Finland Central Hospital</name>
      <address>
        <city>Jyv채skyl채</city>
        <country>Finland</country>
      </address>
    </facility>
    <contact>
      <last_name>Teemu Karjalainen</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kuopio University Hospital</name>
      <address>
        <city>Kuopio</city>
        <country>Finland</country>
      </address>
    </facility>
    <contact>
      <last_name>Yrj채n채 Nietosvaara</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Tampere University Hospital</name>
      <address>
        <city>Tampere</city>
        <country>Finland</country>
      </address>
    </facility>
    <contact>
      <last_name>Jarkko Jokihaara</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Finland</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>November 18, 2021</study_first_submitted>
  <study_first_submitted_qc>November 18, 2021</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 19, 2021</study_first_posted>
  <last_update_submitted>November 18, 2021</last_update_submitted>
  <last_update_submitted_qc>November 18, 2021</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 19, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Tampere University Hospital</investigator_affiliation>
    <investigator_full_name>Jarkko Jokihaara</investigator_full_name>
    <investigator_title>Associate professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>In this trial IPD sharing is restricted by data protection regulations</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

